These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
730 related articles for article (PubMed ID: 29744721)
1. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth. Çelik BN; Mutluay MS; Arıkan V; Sarı Ş Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721 [TBL] [Abstract][Full Text] [Related]
2. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117 [TBL] [Abstract][Full Text] [Related]
3. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up. Frenkel G; Kaufman A; Ashkenazi M J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318 [TBL] [Abstract][Full Text] [Related]
4. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting. Alqaderi HE; Al-Mutawa SA; Qudeimat MA J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732 [TBL] [Abstract][Full Text] [Related]
5. Partial pulpotomy success in primary molars followed up for 24 months: A randomized controlled clinical trial using mineral trioxide aggregate, biodentine, and acemannan. Tungjitphianpong P; Trairatvorakul C; Thunyakitpisal P; Songsiripradubboon S Int J Paediatr Dent; 2024 Sep; 34(5):630-638. PubMed ID: 38297465 [TBL] [Abstract][Full Text] [Related]
6. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study. Carti O; Oznurhan F Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth. Srinivasan D; Jayanthi M Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576 [TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of 2 Calcium Silicate-based Cements (Biodentine and Mineral Trioxide Aggregate) as Direct Pulp-capping Agent in Young Permanent Molars: A Split Mouth Study. Katge FA; Patil DP J Endod; 2017 Apr; 43(4):507-513. PubMed ID: 28216271 [TBL] [Abstract][Full Text] [Related]
9. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study. Olatosi OO; Sote EO; Orenuga OO Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010 [TBL] [Abstract][Full Text] [Related]
10. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial. Bakhtiar H; Nekoofar MH; Aminishakib P; Abedi F; Naghi Moosavi F; Esnaashari E; Azizi A; Esmailian S; Ellini MR; Mesgarzadeh V; Sezavar M; About I J Endod; 2017 Nov; 43(11):1786-1791. PubMed ID: 28822566 [TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial. Malekafzali B; Shekarchi F; Asgary S Eur J Paediatr Dent; 2011 Sep; 12(3):189-93. PubMed ID: 22077689 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of Direct Pulp Capping by Using Either ProRoot Mineral Trioxide Aggregate or Biodentine in Permanent Teeth with Carious Pulp Exposure in 6- to 18-Year-Old Patients: A Randomized Controlled Trial. Parinyaprom N; Nirunsittirat A; Chuveera P; Na Lampang S; Srisuwan T; Sastraruji T; Bua-On P; Simprasert S; Khoipanich I; Sutharaphan T; Theppimarn S; Ue-Srichai N; Tangtrakooljaroen W; Chompu-Inwai P J Endod; 2018 Mar; 44(3):341-348. PubMed ID: 29275850 [TBL] [Abstract][Full Text] [Related]
13. Assessment of MMP levels in reversible and irreversible pulpitis and a randomized controlled trial comparing clinical success of two different calcium-silicate cements in pulpotomy treatment of primary molars with an 18-month follow-up. Gerihan HE; Çoğulu D; Önçağ Ö; Durmaz A; Kuru EH BMC Oral Health; 2024 Aug; 24(1):1020. PubMed ID: 39215293 [TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of primary teeth molar pulpotomies with Biodentine and MTA: a CONSORT randomized clinical trial. Vilella-Pastor S; Sáez S; Veloso A; Guinot-Jimeno F; Mercadé M Eur Arch Paediatr Dent; 2021 Aug; 22(4):685-692. PubMed ID: 33683572 [TBL] [Abstract][Full Text] [Related]
15. Carious Exposure versus Mechanical Exposure for MTA Pulpotomy in Primary Teeth. Çelik BN; Sarı Ş Biomed Res Int; 2016; 2016():2753429. PubMed ID: 27995139 [No Abstract] [Full Text] [Related]
16. Treatment Outcomes of Mineral Trioxide Aggregate Pulpotomy in Vital Permanent Teeth with Carious Pulp Exposure: The Retrospective Study. Linsuwanont P; Wimonsutthikul K; Pothimoke U; Santiwong B J Endod; 2017 Feb; 43(2):225-230. PubMed ID: 28041685 [TBL] [Abstract][Full Text] [Related]
17. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis. Asgary S; Shirvani A; Fazlyab M J Clin Pediatr Dent; 2014; 39(1):1-8. PubMed ID: 25631717 [TBL] [Abstract][Full Text] [Related]
18. Clinical and radiographic success rates of mineral trioxide aggregate and ferric sulphate pulpotomies performed by dental students. Odabaş ME; Alaçam A; Sillelioğlu H; Deveci C Eur J Paediatr Dent; 2012 Jun; 13(2):118-22. PubMed ID: 22762173 [TBL] [Abstract][Full Text] [Related]
19. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Eidelman E; Holan G; Fuks AB Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724 [TBL] [Abstract][Full Text] [Related]
20. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Noorollahian H Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]